Xiaowen Lin has extensive experience in the medical field, particularly in hematology and oncology. They served as the DAH of Hematology, Medical Science at Roche from 2016 to 2018 and held various leadership roles in medical affairs at companies such as Johnson & Johnson and Eli Lilly. Xiaowen earned a master's degree in Clinical and Industrial Drug Development from Peking University Medical School in 2009. Currently, they are contributing to the field as the DAH of Hematology, Medical Science.
This person is not in the org chart
This person is not in any teams
This person is not in any offices